Halozyme Therapeutics (HALO) Shares Cross Above 200 DMA
From Nasdaq.: 2025-01-06 18:32:21
Halozyme Therapeutics Inc (HALO) shares crossed above their 200-day moving average, reaching $50.81 per share, up 5.8% for the day. The 52-week range for HALO is $33.15 to $65.5327, with the last trade at $50.51. The chart shows the performance of HALO shares compared to its 200-day moving average. Check out which other stocks recently crossed their 200-day moving average for potential investment opportunities.
Read more at Nasdaq.: Halozyme Therapeutics (HALO) Shares Cross Above 200 DMA